Evidence map›Paper›PMID 32589125›Full record

SynthesisHealth technology assessment (Winchester, England)2020

Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.

Juliet Hounsome, Gerlinde Pilkington, James Mahon, Angela Boland, Sophie Beale, Eleanor Kotas, Tara Renton, Rumona Dickson

Registry-linked trialOpen access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Health technology assessment (Winchester, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06320665 (Assessment of Vertical Pattern in Correlation With Third Molar Inclusion), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06320665 recruitingnot on this mapstarted 2024, after this paper: background citation

Assessment of Vertical Pattern in Correlation With Third Molar Inclusion : a 3D CBCT Analysis

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan2024 to 2025Enrolled80ConditionsImpacted Third Molar ToothArmsRadiographic measurement
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Expert consensus on the management of third molar health.International journal of oral science · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Juliet HounsomeLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0002-2026-3778
Gerlinde PilkingtonLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0003-0028-0746
James MahonColdingham Analytical Services, Berwickshire, UK.ORCID 0000-0002-2187-1003
Angela BolandLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0002-5435-8644
Sophie BealeLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0003-0164-103X
Eleanor KotasLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0002-8410-6034
Tara RentonOral Surgery, Dental Hospital, King's College London, London, UK.ORCID 0000-0003-2331-4005
Rumona DicksonLiverpoool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.ORCID 0000-0003-1416-0913
University of Liverpool · GBKing's College London · GBR&G Associates · GB

Funding

Department of Health 15/69/16
6 · The paper itself

Abstract

backgroundImpacted third molars are third molars that are blocked, by soft tissue or bone, from fully erupting through the gum. This can cause pain and disease. The treatment options for people with impacted third molars are removal or retention with standard care. If there are pathological changes, the current National Institute for Health and Care Excellence guidance states that the impacted third molar should be removed.

objectiveThe objective of this study was to appraise the clinical effectiveness and cost-effectiveness of the prophylactic removal of impacted mandibular third molars compared with retention of, and standard care for, impacted third molars.

methodsFive electronic databases were searched (1999 to 29 April 2016) to identify relevant evidence [The Cochrane Library (searched 4 April 2016 and 29 April 2016), MEDLINE (searched 4 April 2016 and 29 April 2016), EMBASE (searched 4 April 2016 and 29 April 2016), EconLit (searched 4 April 2016 and 29 April 2016) and NHS Economic Evaluation Database (searched 4 April 2016)]. Studies that compared the prophylactic removal of impacted mandibular third molars with retention and standard care or studies that assessed the outcomes from either approach were included. The clinical outcomes considered were pathology associated with retention, post-operative complications following extraction and adverse effects of treatment. Cost-effectiveness outcomes included UK costs and health-related quality-of-life measures. In addition, the assessment group constructed a de novo economic model to compare the cost-effectiveness of a prophylactic removal strategy with that of retention and standard care.

resultsThe clinical review identified four cohort studies and nine systematic reviews. In the two studies that reported on surgical complications, no serious complications were reported. Pathological changes due to retention of asymptomatic impacted mandibular third molars were reported by three studies. In these studies, the extraction rate for retained impacted mandibular third molars varied from 5.5% to 31.4%; this variation can be explained by the differing follow-up periods (i.e. 1 and 5 years). The findings from this review are consistent with the findings from previous systematic reviews. Two published cost-effectiveness studies were identified. The authors of both studies concluded that, to their knowledge, there is currently no economic evidence to support the prophylactic removal of impacted mandibular third molars. The results generated by the assessment group's lifetime economic model indicated that the incremental cost-effectiveness ratio per quality-adjusted life-year gained for the comparison of a prophylactic removal strategy with a retention and standard care strategy is £11,741 for people aged 20 years with asymptomatic impacted mandibular third molars. The incremental cost per person associated with prophylactic extraction is £55.71, with an incremental quality-adjusted life-year gain of 0.005 per person. The base-case incremental cost-effectiveness ratio per quality-adjusted life-year gained was found to be robust when a range of sensitivity and scenario analyses were carried out. LIMITATIONS: Limitations of the study included that no head-to-head trials comparing the effectiveness of prophylactic removal of impacted mandibular third molars with retention and standard care were identified with the assessment group model that was built on observational data. Utility data on impacted mandibular third molars and their symptoms are lacking.

conclusionsThe evidence comparing the prophylactic removal of impacted mandibular third molars with retention and standard care is very limited. However, the results from an exploratory assessment group model, which uses available evidence on symptom development and extraction rates of retained impacted mandibular third molars, suggest that prophylactic removal may be the more cost-effective strategy. FUTURE WORK: Effectiveness evidence is lacking. Head-to-head trials comparing the prophylactic removal of trouble-free impacted mandibular third molars with retention and watchful waiting are required. If this is not possible, routine clinical data, using common definitions and outcome reporting methods, should be collected. STUDY REGISTRATION: This study is registered as PROSPERO CRD42016037776.

fundingThis project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in

Indexed as

Cost-Benefit AnalysisTreatment OutcomeHumansMolar, ThirdUnited KingdomECONOMIC EVALUATIONIMPACTED THIRD MOLARSIMPACTED WISDOM TEETHPROPHYLACTIC REMOVALSYSTEMATIC REVIEW

Identifiers

PMID32589125
PMCPMC7336222
OpenAlexW3038077315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.